Skip to main content
Alnylam Pharmaceuticals, Inc. (ALNY)
NASDAQ: ALNY · Real-Time Price · USD
323.59
+2.93 (0.91%)
At close: Mar 9, 2026, 4:00 PM EDT
323.10
-0.49 (-0.15%)
After-hours: Mar 9, 2026, 4:50 PM EDT

Alnylam Pharmaceuticals Employees

Alnylam Pharmaceuticals had 2,500 employees as of December 31, 2025. The number of employees increased by 270 or 12.11% compared to the previous year.

Employees
2,500
Change (1Y)
270
Growth (1Y)
12.11%
Revenue / Employee
$1,485,575
Profits / Employee
$125,499
Market Cap
42.92B

Employees Chart

Employees History

Date Employees Change Growth
Dec 31, 20252,50027012.11%
Dec 31, 20242,2301306.19%
Dec 31, 20232,100984.90%
Dec 31, 20222,00233720.24%
Dec 31, 20211,66521214.59%
Dec 31, 20201,4531309.83%
Dec 31, 20191,32325824.23%
Dec 31, 20181,06531642.19%
Dec 31, 201774923545.72%
Dec 31, 201651414539.30%
Dec 31, 201536911344.14%
Dec 31, 20142569155.15%
Dec 31, 20131653627.91%
Dec 31, 20121291311.21%
Dec 31, 2011116-56-32.56%
Dec 31, 2010172-6-3.37%
Dec 31, 200917884.71%
Dec 31, 20081704131.78%
Dec 31, 200712975.74%
Dec 31, 20061222829.79%
Dec 31, 2005942332.39%
Dec 31, 2004711118.33%
Dec 31, 200360--
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.

Related Stocks

Company Name Employees
Regeneron Pharmaceuticals 15,410
BeOne Medicines AG 12,000
BioNTech SE 6,772
Moderna 4,700
Genmab 2,973
Incyte 2,844
Insmed 1,664
argenx SE 1,599
Employee Rankings

ALNY News

More News